ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC

March 12, 1982

NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept

May 22, 1981

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987